Royalty Pharma shares owned by Vantage Consulting Group
Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Vantage Consulting Group
from 13F filings
Historical chart of Vantage Consulting Group investment in Royalty Pharma
Tip: Access up to 7 years of quarterly data
All positions including Royalty Pharma held by Vantage Consulting Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Royalty Pharma by Vantage Consulting Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $1.6M | 58k | 27.14 |
| 2023-06-30 | $20M | 651k | 30.74 |
| 2023-03-31 | $37M | 1.0M | 36.03 |
| 2022-12-31 | $36M | 1.0M | 34.69 |
| 2022-09-30 | $41M | 1.0M | 40.18 |
| 2022-06-30 | $44M | 1.1M | 42.04 |
| 2022-03-31 | $106M | 2.7M | 38.96 |
| 2021-12-31 | $183M | 4.6M | 39.85 |
| 2021-09-30 | $284M | 7.9M | 36.14 |
| 2021-06-30 | $381M | 9.3M | 40.99 |
| 2021-03-31 | $380M | 8.7M | 43.62 |
| 2020-12-31 | $1.1B | 22M | 50.05 |
More positions owned by Vantage Consulting Group
View all positions for Vantage Consulting Group